Lynda Dzubinski

2PUBLICATIONS
43CO-AUTHORS
Predictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (2)

|Jun 09, 2023
Elevated EVL Methylation Level in the Normal Colon Mucosa Is a Potential Risk Biomarker for Developing Recurrent Adenomas.

Ming Yu, Kelly T Carter, Kelsey K Baker

|Mar 09, 2023
Randomized, Double-Blind, Placebo-Controlled Trial of MUC1 Peptide Vaccine for Prevention of Recurrent Colorectal Adenoma.

Robert E Schoen, Lisa A Boardman, Marcia Cruz-Correa

Pageof 1